chrX-11761513-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_078629.4(MSL3):c.396C>T(p.Ser132=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00532 in 1,196,392 control chromosomes in the GnomAD database, including 205 homozygotes. There are 1,694 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.027 ( 104 hom., 840 hem., cov: 24)
Exomes 𝑓: 0.0030 ( 101 hom. 854 hem. )
Consequence
MSL3
NM_078629.4 synonymous
NM_078629.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.43
Genes affected
MSL3 (HGNC:7370): (MSL complex subunit 3) This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-11761513-C-T is Benign according to our data. Variant chrX-11761513-C-T is described in ClinVar as [Benign]. Clinvar id is 3041463.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=1.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0914 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSL3 | NM_078629.4 | c.396C>T | p.Ser132= | synonymous_variant | 5/13 | ENST00000312196.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSL3 | ENST00000312196.10 | c.396C>T | p.Ser132= | synonymous_variant | 5/13 | 1 | NM_078629.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0273 AC: 3056AN: 111934Hom.: 103 Cov.: 24 AF XY: 0.0245 AC XY: 838AN XY: 34144
GnomAD3 genomes
AF:
AC:
3056
AN:
111934
Hom.:
Cov.:
24
AF XY:
AC XY:
838
AN XY:
34144
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00833 AC: 1425AN: 171162Hom.: 50 AF XY: 0.00503 AC XY: 288AN XY: 57200
GnomAD3 exomes
AF:
AC:
1425
AN:
171162
Hom.:
AF XY:
AC XY:
288
AN XY:
57200
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00304 AC: 3298AN: 1084407Hom.: 101 Cov.: 25 AF XY: 0.00243 AC XY: 854AN XY: 351767
GnomAD4 exome
AF:
AC:
3298
AN:
1084407
Hom.:
Cov.:
25
AF XY:
AC XY:
854
AN XY:
351767
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0273 AC: 3061AN: 111985Hom.: 104 Cov.: 24 AF XY: 0.0246 AC XY: 840AN XY: 34205
GnomAD4 genome
AF:
AC:
3061
AN:
111985
Hom.:
Cov.:
24
AF XY:
AC XY:
840
AN XY:
34205
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MSL3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at